Sum up, lncRNA TUG1 have been used as a biomarker in esophageal squamous cell carcinoma, viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma, NBNC-HCC, lung cancer, bladder cancer, ovarian cancer, osteosarcoma and R/R AML. This evidence concerns the gene TUG1 and urinary bladder carcinoma.